APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nitinol Revascularization Device

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Nitinol Revascularization Device Market Outlook and Growth Opportunities 2026

27 December 2025204 pages

Choose your research edition.

Industry ResearchNitinol Revascularization Device Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Nitinol Revascularization Device Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Nitinol Revascularization Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nitinol Revascularization Device Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Nitinol Revascularization Device Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Nitinol Revascularization Device market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Nitinol Revascularization Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Nitinol Revascularization Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nitinol Revascularization Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Nitinol Revascularization Device market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Nitinol Revascularization Device market include Acandis GmbH, Balt Group, Furukawa Techno Material, Johnson & Johnson MedTech, Penumbra, Rapid Medical, Stryker, Guichuangtongqiao Medical and Hemu Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Nitinol Revascularization Device market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nitinol Revascularization Device and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nitinol Revascularization Device sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Nitinol Revascularization Device market size, projected growth trends, production technologies, key applications, and end-use industries.

Nitinol Revascularization Device Segment by Company

Acandis GmbH

Balt Group

Furukawa Techno Material

Johnson & Johnson MedTech

Penumbra

Rapid Medical

Stryker

Guichuangtongqiao Medical

Hemu Biotech

Jianshi Medical

Medtronic

Sinoshenchang Medical

Suzhou Zhongtian Medical

Micro-Port Shentong Medical

Xinkainuo Medical

Xinwei Medical

Nitinol Revascularization Device Segment by Type

Diameter 6MM

Diameter 4MM

Diameter 3MM

Other

Nitinol Revascularization Device Segment by Application

Hospital

Clinic

Other

Nitinol Revascularization Device Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Nitinol Revascularization Device status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Nitinol Revascularization Device market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Nitinol Revascularization Device significant trends, drivers, influence factors in global and regions.

6. To analyze Nitinol Revascularization Device competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nitinol Revascularization Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nitinol Revascularization Device and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nitinol Revascularization Device.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Nitinol Revascularization Device market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Nitinol Revascularization Device industry.

Chapter 3: Detailed analysis of Nitinol Revascularization Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Nitinol Revascularization Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Nitinol Revascularization Device in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Nitinol Revascularization Device Industry Trends Table 2. Nitinol Revascularization Device Industry Drivers Table 3. Nitinol Revascularization Device Industry Opportunities and Challenges Table 4. Nitinol Revascularization Device Industry Restraints Table 5. Global Nitinol Revascularization Device Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Nitinol Revascularization Device Revenue Share by Company (2021-2026) Table 7. Global Nitinol Revascularization Device Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Nitinol Revascularization Device Sales Volume Share by Company (2021-2026) Table 9. Global Nitinol Revascularization Device Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Nitinol Revascularization Device Company Ranking, (2024-2026) & (USD Million) Table 11. Global Nitinol Revascularization Device Key Company Manufacturing Base & Headquarters Table 12. Global Nitinol Revascularization Device Company, Product Type & Application Table 13. Global Nitinol Revascularization Device Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Nitinol Revascularization Device by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Diameter 6MM Table 18. Significant Companies of Diameter 4MM Table 19. Significant Companies of Diameter 3MM Table 20. Significant Companies of Other Table 21. Global Nitinol Revascularization Device Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Nitinol Revascularization Device Sales Volume by Type (2021-2026) & (K Units) Table 23. Global Nitinol Revascularization Device Sales Volume by Type (2027-2032) & (K Units) Table 24. Global Nitinol Revascularization Device Sales Volume Share by Type (2021-2026) Table 25. Global Nitinol Revascularization Device Sales Volume Share by Type (2027-2032) Table 26. Global Nitinol Revascularization Device Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Nitinol Revascularization Device Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Nitinol Revascularization Device Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Nitinol Revascularization Device Sales Value Share by Type (2021-2026) Table 30. Global Nitinol Revascularization Device Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Hospital Table 32. Significant Companies of Clinic Table 33. Significant Companies of Other Table 34. Global Nitinol Revascularization Device Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Nitinol Revascularization Device Sales Volume by Application (2021-2026) & (K Units) Table 36. Global Nitinol Revascularization Device Sales Volume by Application (2027-2032) & (K Units) Table 37. Global Nitinol Revascularization Device Sales Volume Share by Application (2021-2026) Table 38. Global Nitinol Revascularization Device Sales Volume Share by Application (2027-2032) Table 39. Global Nitinol Revascularization Device Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Nitinol Revascularization Device Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Nitinol Revascularization Device Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Nitinol Revascularization Device Sales Value Share by Application (2021-2026) Table 43. Global Nitinol Revascularization Device Sales Value Share by Application (2027-2032) Table 44. Global Nitinol Revascularization Device Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Nitinol Revascularization Device Sales by Region (2021-2026) & (K Units) Table 46. Global Nitinol Revascularization Device Sales Market Share by Region (2021-2026) Table 47. Global Nitinol Revascularization Device Sales by Region (2027-2032) & (K Units) Table 48. Global Nitinol Revascularization Device Sales Market Share by Region (2027-2032) Table 49. Global Nitinol Revascularization Device Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Nitinol Revascularization Device Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Nitinol Revascularization Device Sales Value Share by Region (2021-2026) Table 52. Global Nitinol Revascularization Device Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Nitinol Revascularization Device Sales Value Share by Region (2027-2032) Table 54. Global Nitinol Revascularization Device Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Nitinol Revascularization Device Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Nitinol Revascularization Device Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global Nitinol Revascularization Device Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Nitinol Revascularization Device Sales by Country (2021-2026) & (K Units) Table 59. Global Nitinol Revascularization Device Sales Market Share by Country (2021-2026) Table 60. Global Nitinol Revascularization Device Sales by Country (2027-2032) & (K Units) Table 61. Global Nitinol Revascularization Device Sales Market Share by Country (2027-2032) Table 62. Global Nitinol Revascularization Device Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Nitinol Revascularization Device Sales Value Market Share by Country (2021-2026) Table 64. Global Nitinol Revascularization Device Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Nitinol Revascularization Device Sales Value Market Share by Country (2027-2032) Table 66. Acandis GmbH Company Information Table 67. Acandis GmbH Business Overview Table 68. Acandis GmbH Nitinol Revascularization Device Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Acandis GmbH Nitinol Revascularization Device Product Portfolio Table 70. Acandis GmbH Recent Development Table 71. Balt Group Company Information Table 72. Balt Group Business Overview Table 73. Balt Group Nitinol Revascularization Device Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Balt Group Nitinol Revascularization Device Product Portfolio Table 75. Balt Group Recent Development Table 76. Furukawa Techno Material Company Information Table 77. Furukawa Techno Material Business Overview Table 78. Furukawa Techno Material Nitinol Revascularization Device Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Furukawa Techno Material Nitinol Revascularization Device Product Portfolio Table 80. Furukawa Techno Material Recent Development Table 81. Johnson & Johnson MedTech Company Information Table 82. Johnson & Johnson MedTech Business Overview Table 83. Johnson & Johnson MedTech Nitinol Revascularization Device Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Johnson & Johnson MedTech Nitinol Revascularization Device Product Portfolio Table 85. Johnson & Johnson MedTech Recent Development Table 86. Penumbra Company Information Table 87. Penumbra Business Overview Table 88. Penumbra Nitinol Revascularization Device Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Penumbra Nitinol Revascularization Device Product Portfolio Table 90. Penumbra Recent Development Table 91. Rapid Medical Company Information Table 92. Rapid Medical Business Overview Table 93. Rapid Medical Nitinol Revascularization Device Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Rapid Medical Nitinol Revascularization Device Product Portfolio Table 95. Rapid Medical Recent Development Table 96. Stryker Company Information Table 97. Stryker Business Overview Table 98. Stryker Nitinol Revascularization Device Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Stryker Nitinol Revascularization Device Product Portfolio Table 100. Stryker Recent Development Table 101. Guichuangtongqiao Medical Company Information Table 102. Guichuangtongqiao Medical Business Overview Table 103. Guichuangtongqiao Medical Nitinol Revascularization Device Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Guichuangtongqiao Medical Nitinol Revascularization Device Product Portfolio Table 105. Guichuangtongqiao Medical Recent Development Table 106. Hemu Biotech Company Information Table 107. Hemu Biotech Business Overview Table 108. Hemu Biotech Nitinol Revascularization Device Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Hemu Biotech Nitinol Revascularization Device Product Portfolio Table 110. Hemu Biotech Recent Development Table 111. Jianshi Medical Company Information Table 112. Jianshi Medical Business Overview Table 113. Jianshi Medical Nitinol Revascularization Device Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Jianshi Medical Nitinol Revascularization Device Product Portfolio Table 115. Jianshi Medical Recent Development Table 116. Medtronic Company Information Table 117. Medtronic Business Overview Table 118. Medtronic Nitinol Revascularization Device Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Medtronic Nitinol Revascularization Device Product Portfolio Table 120. Medtronic Recent Development Table 121. Sinoshenchang Medical Company Information Table 122. Sinoshenchang Medical Business Overview Table 123. Sinoshenchang Medical Nitinol Revascularization Device Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Sinoshenchang Medical Nitinol Revascularization Device Product Portfolio Table 125. Sinoshenchang Medical Recent Development Table 126. Suzhou Zhongtian Medical Company Information Table 127. Suzhou Zhongtian Medical Business Overview Table 128. Suzhou Zhongtian Medical Nitinol Revascularization Device Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Suzhou Zhongtian Medical Nitinol Revascularization Device Product Portfolio Table 130. Suzhou Zhongtian Medical Recent Development Table 131. Micro-Port Shentong Medical Company Information Table 132. Micro-Port Shentong Medical Business Overview Table 133. Micro-Port Shentong Medical Nitinol Revascularization Device Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Micro-Port Shentong Medical Nitinol Revascularization Device Product Portfolio Table 135. Micro-Port Shentong Medical Recent Development Table 136. Xinkainuo Medical Company Information Table 137. Xinkainuo Medical Business Overview Table 138. Xinkainuo Medical Nitinol Revascularization Device Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Xinkainuo Medical Nitinol Revascularization Device Product Portfolio Table 140. Xinkainuo Medical Recent Development Table 141. Xinwei Medical Company Information Table 142. Xinwei Medical Business Overview Table 143. Xinwei Medical Nitinol Revascularization Device Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Xinwei Medical Nitinol Revascularization Device Product Portfolio Table 145. Xinwei Medical Recent Development Table 146. Key Raw Materials Table 147. Raw Materials Key Suppliers Table 148. Nitinol Revascularization Device Distributors List Table 149. Nitinol Revascularization Device Customers List Table 150. Research Programs/Design for This Report Table 151. Authors List of This Report Table 152. Secondary Sources Table 153. Primary Sources List of Figures Figure 1. Nitinol Revascularization Device Product Image Figure 2. Global Nitinol Revascularization Device Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nitinol Revascularization Device Sales Value (2021-2032) & (US$ Million) Figure 4. Global Nitinol Revascularization Device Sales (2021-2032) & (K Units) Figure 5. Global Nitinol Revascularization Device Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Nitinol Revascularization Device Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Diameter 6MM Image Figure 10. Diameter 4MM Image Figure 11. Diameter 3MM Image Figure 12. Other Image Figure 13. Global Nitinol Revascularization Device Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Nitinol Revascularization Device Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Nitinol Revascularization Device Sales Volume Share by Type (2021-2032) Figure 16. Global Nitinol Revascularization Device Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Nitinol Revascularization Device Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Nitinol Revascularization Device Sales Value Share by Type (2021-2032) Figure 19. Hospital Image Figure 20. Clinic Image Figure 21. Other Image Figure 22. Global Nitinol Revascularization Device Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Nitinol Revascularization Device Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Nitinol Revascularization Device Sales Volume Share by Application (2021-2032) Figure 25. Global Nitinol Revascularization Device Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Nitinol Revascularization Device Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Nitinol Revascularization Device Sales Value Share by Application (2021-2032) Figure 28. Global Nitinol Revascularization Device Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global Nitinol Revascularization Device Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Nitinol Revascularization Device Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Nitinol Revascularization Device Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Nitinol Revascularization Device Sales Value (2021-2032) & (US$ Million) Figure 33. North America Nitinol Revascularization Device Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Nitinol Revascularization Device Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Nitinol Revascularization Device Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Nitinol Revascularization Device Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Nitinol Revascularization Device Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Nitinol Revascularization Device Sales Value (2021-2032) & (US$ Million) Figure 39. South America Nitinol Revascularization Device Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Nitinol Revascularization Device Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Nitinol Revascularization Device Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Nitinol Revascularization Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Nitinol Revascularization Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Nitinol Revascularization Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Nitinol Revascularization Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Nitinol Revascularization Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Nitinol Revascularization Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Nitinol Revascularization Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Nitinol Revascularization Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Nitinol Revascularization Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Nitinol Revascularization Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Nitinol Revascularization Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Nitinol Revascularization Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Nitinol Revascularization Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Nitinol Revascularization Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Nitinol Revascularization Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Nitinol Revascularization Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Nitinol Revascularization Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Nitinol Revascularization Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Nitinol Revascularization Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Nitinol Revascularization Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Nitinol Revascularization Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Nitinol Revascularization Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Nitinol Revascularization Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Nitinol Revascularization Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Nitinol Revascularization Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Nitinol Revascularization Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Nitinol Revascularization Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Nitinol Revascularization Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Nitinol Revascularization Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Nitinol Revascularization Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Nitinol Revascularization Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Nitinol Revascularization Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Nitinol Revascularization Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Nitinol Revascularization Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Nitinol Revascularization Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Nitinol Revascularization Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Nitinol Revascularization Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Nitinol Revascularization Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Nitinol Revascularization Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Nitinol Revascularization Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Nitinol Revascularization Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Nitinol Revascularization Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Nitinol Revascularization Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Nitinol Revascularization Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Nitinol Revascularization Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Nitinol Revascularization Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Nitinol Revascularization Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Nitinol Revascularization Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Nitinol Revascularization Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Nitinol Revascularization Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Nitinol Revascularization Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Nitinol Revascularization Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Nitinol Revascularization Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Nitinol Revascularization Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Nitinol Revascularization Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Nitinol Revascularization Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Nitinol Revascularization Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Nitinol Revascularization Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Nitinol Revascularization Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Nitinol Revascularization Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Nitinol Revascularization Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Nitinol Revascularization Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Nitinol Revascularization Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Nitinol Revascularization Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Nitinol Revascularization Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Nitinol Revascularization Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Nitinol Revascularization Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Nitinol Revascularization Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Nitinol Revascularization Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Nitinol Revascularization Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Nitinol Revascularization Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Nitinol Revascularization Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Nitinol Revascularization Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Nitinol Revascularization Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Nitinol Revascularization Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Nitinol Revascularization Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Nitinol Revascularization Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Nitinol Revascularization Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Nitinol Revascularization Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Nitinol Revascularization Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Nitinol Revascularization Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Nitinol Revascularization Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Nitinol Revascularization Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Nitinol Revascularization Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Nitinol Revascularization Device Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Nitinol Revascularization Device Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Diameter 6MM
  • Diameter 4MM
  • Diameter 3MM
  • Other
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Acandis GmbH
  • Balt Group
  • Furukawa Techno Material
  • Johnson & Johnson MedTech
  • Penumbra
  • Rapid Medical
  • Stryker
  • Guichuangtongqiao Medical
  • Hemu Biotech
  • Jianshi Medical
  • Medtronic
  • Sinoshenchang Medical
  • Suzhou Zhongtian Medical
  • Micro-Port Shentong Medical
  • Xinkainuo Medical
  • Xinwei Medical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Nitinol Revascularization Device Sales Value (2021-2032)
  4. 1.2.2 Global Nitinol Revascularization Device Sales Volume (2021-2032)
  5. 1.2.3 Global Nitinol Revascularization Device Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Nitinol Revascularization Device Market Dynamics
  1. 2.1 Nitinol Revascularization Device Industry Trends
  2. 2.2 Nitinol Revascularization Device Industry Drivers
  3. 2.3 Nitinol Revascularization Device Industry Opportunities and Challenges
  4. 2.4 Nitinol Revascularization Device Industry Restraints
3 Nitinol Revascularization Device Market by Company
  1. 3.1 Global Nitinol Revascularization Device Company Revenue Ranking in 2025
  2. 3.2 Global Nitinol Revascularization Device Revenue by Company (2021-2026)
  3. 3.3 Global Nitinol Revascularization Device Sales Volume by Company (2021-2026)
  4. 3.4 Global Nitinol Revascularization Device Average Price by Company (2021-2026)
  5. 3.5 Global Nitinol Revascularization Device Company Ranking (2024-2026)
  6. 3.6 Global Nitinol Revascularization Device Company Manufacturing Base and Headquarters
  7. 3.7 Global Nitinol Revascularization Device Company Product Type and Application
  8. 3.8 Global Nitinol Revascularization Device Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Nitinol Revascularization Device Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Nitinol Revascularization Device Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Nitinol Revascularization Device Market by Type
  1. 4.1 Nitinol Revascularization Device Type Introduction
  2. 4.1.1 Diameter 6MM
  3. 4.1.2 Diameter 4MM
  4. 4.1.3 Diameter 3MM
  5. 4.1.4 Other
  6. 4.2 Global Nitinol Revascularization Device Sales Volume by Type
  7. 4.2.1 Global Nitinol Revascularization Device Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Nitinol Revascularization Device Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Nitinol Revascularization Device Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Nitinol Revascularization Device Sales Value by Type
  11. 4.3.1 Global Nitinol Revascularization Device Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Nitinol Revascularization Device Sales Value by Type (2021-2032)
  13. 4.3.3 Global Nitinol Revascularization Device Sales Value Share by Type (2021-2032)
5 Nitinol Revascularization Device Market by Application
  1. 5.1 Nitinol Revascularization Device Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Nitinol Revascularization Device Sales Volume by Application
  6. 5.2.1 Global Nitinol Revascularization Device Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Nitinol Revascularization Device Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Nitinol Revascularization Device Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Nitinol Revascularization Device Sales Value by Application
  10. 5.3.1 Global Nitinol Revascularization Device Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Nitinol Revascularization Device Sales Value by Application (2021-2032)
  12. 5.3.3 Global Nitinol Revascularization Device Sales Value Share by Application (2021-2032)
6 Nitinol Revascularization Device Regional Sales and Value Analysis
  1. 6.1 Global Nitinol Revascularization Device Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Nitinol Revascularization Device Sales by Region (2021-2032)
  3. 6.2.1 Global Nitinol Revascularization Device Sales by Region: 2021-2026
  4. 6.2.2 Global Nitinol Revascularization Device Sales by Region (2027-2032)
  5. 6.3 Global Nitinol Revascularization Device Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Nitinol Revascularization Device Sales Value by Region (2021-2032)
  7. 6.4.1 Global Nitinol Revascularization Device Sales Value by Region: 2021-2026
  8. 6.4.2 Global Nitinol Revascularization Device Sales Value by Region (2027-2032)
  9. 6.5 Global Nitinol Revascularization Device Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Nitinol Revascularization Device Sales Value (2021-2032)
  12. 6.6.2 North America Nitinol Revascularization Device Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Nitinol Revascularization Device Sales Value (2021-2032)
  15. 6.7.2 Europe Nitinol Revascularization Device Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Nitinol Revascularization Device Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Nitinol Revascularization Device Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Nitinol Revascularization Device Sales Value (2021-2032)
  21. 6.9.2 South America Nitinol Revascularization Device Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Nitinol Revascularization Device Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Nitinol Revascularization Device Sales Value Share by Country, 2025 VS 2032
7 Nitinol Revascularization Device Country-level Sales and Value Analysis
  1. 7.1 Global Nitinol Revascularization Device Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Nitinol Revascularization Device Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Nitinol Revascularization Device Sales by Country (2021-2032)
  4. 7.3.1 Global Nitinol Revascularization Device Sales by Country (2021-2026)
  5. 7.3.2 Global Nitinol Revascularization Device Sales by Country (2027-2032)
  6. 7.4 Global Nitinol Revascularization Device Sales Value by Country (2021-2032)
  7. 7.4.1 Global Nitinol Revascularization Device Sales Value by Country (2021-2026)
  8. 7.4.2 Global Nitinol Revascularization Device Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Nitinol Revascularization Device Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Nitinol Revascularization Device Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Nitinol Revascularization Device Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Nitinol Revascularization Device Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Nitinol Revascularization Device Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Nitinol Revascularization Device Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Nitinol Revascularization Device Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Nitinol Revascularization Device Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Nitinol Revascularization Device Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Nitinol Revascularization Device Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Nitinol Revascularization Device Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Nitinol Revascularization Device Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Nitinol Revascularization Device Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Nitinol Revascularization Device Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Nitinol Revascularization Device Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Nitinol Revascularization Device Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Nitinol Revascularization Device Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Nitinol Revascularization Device Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Nitinol Revascularization Device Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Nitinol Revascularization Device Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Nitinol Revascularization Device Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Nitinol Revascularization Device Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Nitinol Revascularization Device Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Nitinol Revascularization Device Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Nitinol Revascularization Device Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Nitinol Revascularization Device Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Nitinol Revascularization Device Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Nitinol Revascularization Device Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Nitinol Revascularization Device Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Nitinol Revascularization Device Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Nitinol Revascularization Device Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Nitinol Revascularization Device Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Nitinol Revascularization Device Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Nitinol Revascularization Device Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Nitinol Revascularization Device Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Nitinol Revascularization Device Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Nitinol Revascularization Device Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Nitinol Revascularization Device Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Nitinol Revascularization Device Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Nitinol Revascularization Device Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Nitinol Revascularization Device Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Nitinol Revascularization Device Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Nitinol Revascularization Device Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Nitinol Revascularization Device Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Nitinol Revascularization Device Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Nitinol Revascularization Device Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Nitinol Revascularization Device Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Nitinol Revascularization Device Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Nitinol Revascularization Device Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Nitinol Revascularization Device Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Nitinol Revascularization Device Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Nitinol Revascularization Device Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Nitinol Revascularization Device Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Nitinol Revascularization Device Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Nitinol Revascularization Device Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Nitinol Revascularization Device Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Nitinol Revascularization Device Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Nitinol Revascularization Device Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Nitinol Revascularization Device Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Nitinol Revascularization Device Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Nitinol Revascularization Device Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Nitinol Revascularization Device Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Nitinol Revascularization Device Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Nitinol Revascularization Device Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Nitinol Revascularization Device Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Nitinol Revascularization Device Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Nitinol Revascularization Device Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Nitinol Revascularization Device Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Nitinol Revascularization Device Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Nitinol Revascularization Device Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Nitinol Revascularization Device Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Nitinol Revascularization Device Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Nitinol Revascularization Device Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Nitinol Revascularization Device Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Nitinol Revascularization Device Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Nitinol Revascularization Device Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Nitinol Revascularization Device Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Nitinol Revascularization Device Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Nitinol Revascularization Device Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Nitinol Revascularization Device Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Nitinol Revascularization Device Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Nitinol Revascularization Device Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Nitinol Revascularization Device Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Nitinol Revascularization Device Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Acandis GmbH
  2. 8.1.1 Acandis GmbH Company Information
  3. 8.1.2 Acandis GmbH Business Overview
  4. 8.1.3 Acandis GmbH Nitinol Revascularization Device Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Acandis GmbH Nitinol Revascularization Device Product Portfolio
  6. 8.1.5 Acandis GmbH Recent Developments
  7. 8.2 Balt Group
  8. 8.2.1 Balt Group Company Information
  9. 8.2.2 Balt Group Business Overview
  10. 8.2.3 Balt Group Nitinol Revascularization Device Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Balt Group Nitinol Revascularization Device Product Portfolio
  12. 8.2.5 Balt Group Recent Developments
  13. 8.3 Furukawa Techno Material
  14. 8.3.1 Furukawa Techno Material Company Information
  15. 8.3.2 Furukawa Techno Material Business Overview
  16. 8.3.3 Furukawa Techno Material Nitinol Revascularization Device Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Furukawa Techno Material Nitinol Revascularization Device Product Portfolio
  18. 8.3.5 Furukawa Techno Material Recent Developments
  19. 8.4 Johnson & Johnson MedTech
  20. 8.4.1 Johnson & Johnson MedTech Company Information
  21. 8.4.2 Johnson & Johnson MedTech Business Overview
  22. 8.4.3 Johnson & Johnson MedTech Nitinol Revascularization Device Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Johnson & Johnson MedTech Nitinol Revascularization Device Product Portfolio
  24. 8.4.5 Johnson & Johnson MedTech Recent Developments
  25. 8.5 Penumbra
  26. 8.5.1 Penumbra Company Information
  27. 8.5.2 Penumbra Business Overview
  28. 8.5.3 Penumbra Nitinol Revascularization Device Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Penumbra Nitinol Revascularization Device Product Portfolio
  30. 8.5.5 Penumbra Recent Developments
  31. 8.6 Rapid Medical
  32. 8.6.1 Rapid Medical Company Information
  33. 8.6.2 Rapid Medical Business Overview
  34. 8.6.3 Rapid Medical Nitinol Revascularization Device Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Rapid Medical Nitinol Revascularization Device Product Portfolio
  36. 8.6.5 Rapid Medical Recent Developments
  37. 8.7 Stryker
  38. 8.7.1 Stryker Company Information
  39. 8.7.2 Stryker Business Overview
  40. 8.7.3 Stryker Nitinol Revascularization Device Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Stryker Nitinol Revascularization Device Product Portfolio
  42. 8.7.5 Stryker Recent Developments
  43. 8.8 Guichuangtongqiao Medical
  44. 8.8.1 Guichuangtongqiao Medical Company Information
  45. 8.8.2 Guichuangtongqiao Medical Business Overview
  46. 8.8.3 Guichuangtongqiao Medical Nitinol Revascularization Device Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Guichuangtongqiao Medical Nitinol Revascularization Device Product Portfolio
  48. 8.8.5 Guichuangtongqiao Medical Recent Developments
  49. 8.9 Hemu Biotech
  50. 8.9.1 Hemu Biotech Company Information
  51. 8.9.2 Hemu Biotech Business Overview
  52. 8.9.3 Hemu Biotech Nitinol Revascularization Device Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Hemu Biotech Nitinol Revascularization Device Product Portfolio
  54. 8.9.5 Hemu Biotech Recent Developments
  55. 8.10 Jianshi Medical
  56. 8.10.1 Jianshi Medical Company Information
  57. 8.10.2 Jianshi Medical Business Overview
  58. 8.10.3 Jianshi Medical Nitinol Revascularization Device Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Jianshi Medical Nitinol Revascularization Device Product Portfolio
  60. 8.10.5 Jianshi Medical Recent Developments
  61. 8.11 Medtronic
  62. 8.11.1 Medtronic Company Information
  63. 8.11.2 Medtronic Business Overview
  64. 8.11.3 Medtronic Nitinol Revascularization Device Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Medtronic Nitinol Revascularization Device Product Portfolio
  66. 8.11.5 Medtronic Recent Developments
  67. 8.12 Sinoshenchang Medical
  68. 8.12.1 Sinoshenchang Medical Company Information
  69. 8.12.2 Sinoshenchang Medical Business Overview
  70. 8.12.3 Sinoshenchang Medical Nitinol Revascularization Device Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Sinoshenchang Medical Nitinol Revascularization Device Product Portfolio
  72. 8.12.5 Sinoshenchang Medical Recent Developments
  73. 8.13 Suzhou Zhongtian Medical
  74. 8.13.1 Suzhou Zhongtian Medical Company Information
  75. 8.13.2 Suzhou Zhongtian Medical Business Overview
  76. 8.13.3 Suzhou Zhongtian Medical Nitinol Revascularization Device Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Suzhou Zhongtian Medical Nitinol Revascularization Device Product Portfolio
  78. 8.13.5 Suzhou Zhongtian Medical Recent Developments
  79. 8.14 Micro-Port Shentong Medical
  80. 8.14.1 Micro-Port Shentong Medical Company Information
  81. 8.14.2 Micro-Port Shentong Medical Business Overview
  82. 8.14.3 Micro-Port Shentong Medical Nitinol Revascularization Device Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Micro-Port Shentong Medical Nitinol Revascularization Device Product Portfolio
  84. 8.14.5 Micro-Port Shentong Medical Recent Developments
  85. 8.15 Xinkainuo Medical
  86. 8.15.1 Xinkainuo Medical Company Information
  87. 8.15.2 Xinkainuo Medical Business Overview
  88. 8.15.3 Xinkainuo Medical Nitinol Revascularization Device Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Xinkainuo Medical Nitinol Revascularization Device Product Portfolio
  90. 8.15.5 Xinkainuo Medical Recent Developments
  91. 8.16 Xinwei Medical
  92. 8.16.1 Xinwei Medical Company Information
  93. 8.16.2 Xinwei Medical Business Overview
  94. 8.16.3 Xinwei Medical Nitinol Revascularization Device Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Xinwei Medical Nitinol Revascularization Device Product Portfolio
  96. 8.16.5 Xinwei Medical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Nitinol Revascularization Device Value Chain Analysis
  2. 9.1.1 Nitinol Revascularization Device Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Nitinol Revascularization Device Sales Mode & Process
  6. 9.2 Nitinol Revascularization Device Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Nitinol Revascularization Device Distributors
  9. 9.2.3 Nitinol Revascularization Device Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst